Private Market View

SWARM Biotactics

Kassel, Germany · Founded 2024 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
$14.6M
Last round

Key facts

  • It has raised $14.6M; the latest was Seed Round ($11.4M) in Jun 2025.
  • Notable investors include Possible Ventures, Capnamic Ventures, Vertex Ventures US, Tholus Capital, Sentris Capital.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 5 names
  • ·Watchlist + deal alerts for SWARM Biotactics
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for SWARM Biotactics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About SWARM Biotactics

Developer of biorobotics technology intended to create bio-robots for mission-critical applications. The company's technology is equipped with custom-designed backpacks for control, sensing, and secure communication, to operate in environments where conventional robotics fails, enabling users to get silent access, close-range ISR, and real-time data collection facilities.

Sector
Information Technology
HQ
Kassel, Germany
Founded
2024
Employees
30
Ownership
Privately Held (backing)
PA Mark — not yet priced

SWARM Biotactics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in SWARM Biotactics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on SWARM Biotactics in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.